Infusystem Holdings vs Rxsight
Infusystem Holdings and Rxsight are similar in size: $143m and $134m of revenue in their latest fiscal years. Infusystem Holdings grew faster (6.4% against -3.9%). Infusystem Holdings kept more of each dollar of sales as profit: a net margin of 4.6% against -29.0%. Rxsight carries less debt relative to equity (0.0% against 34.9%).
| Latest fiscal year | Infusystem HoldingsINFU, 2025 | RxsightRXST, 2025 |
|---|---|---|
| Revenue | $143m | $134m |
| Revenue growth | 6.4% | -3.9% |
| Net income | $6.6m | −$38.9m |
| Operating margin | 8.3% | -35.8% |
| Net margin | 4.6% | -29.0% |
| Return on equity | 11.5% | -14.0% |
| Free cash flow | $23.8m | −$19.3m |
| Cash | $3.2m | $19.9m |
| Total debt | $20.0m | $0 |
| Debt to equity | 34.9% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $9.9m | — |
| Employees | 473 | 461 |
| Market value | $255m | $192m |
| Price vs our value range | Within our value range | — |
| Moat score | 64 (Moderate) | 27 (Weak) |
| Insider trades, 12 months | 5 buys, 0 sales | 0 buys, 4 sales |